The work of the WHO Consultative Group on Poliomyelitis Vaccines.
作者信息
Cockburn W C
出版信息
Bull World Health Organ. 1988;66(2):143-54.
Abstract
摘要
相似文献
1
The work of the WHO Consultative Group on Poliomyelitis Vaccines.世界卫生组织脊髓灰质炎疫苗咨询小组的工作。
Bull World Health Organ. 1988;66(2):143-54.
2
The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry.急性持续性脊髓麻痹与口服脊髓灰质炎疫苗之间的关系：世界卫生组织调查结果
Bull World Health Organ. 1976;53(4):319-31.
3
4
Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.对从伊朗疫苗相关麻痹型脊髓灰质炎病例中分离出的1型脊髓灰质炎病毒萨宾株VP(1)区域突变的特征分析。
J Clin Virol. 2007 Aug;39(4):304-7. doi: 10.1016/j.jcv.2007.04.017. Epub 2007 Jun 21.
5
The relation between acute persisting spinal paralysis and poliomyelitis vaccine--results of a ten-year enquiry. WHO Consultative Group.急性持续性脊髓麻痹与脊髓灰质炎疫苗的关系——十年调查结果。世界卫生组织咨询小组
Bull World Health Organ. 1982;60(2):231-42.
6
On the role of the World Health Organization in the development of Sabin vaccines.论世界卫生组织在萨宾疫苗研发中的作用。
Biologicals. 1993 Dec;21(4):345-8. doi: 10.1006/biol.1993.1094.
7
WHO recommendation on potential use of new poliomyelitis vaccines.世界卫生组织关于新型脊髓灰质炎疫苗潜在用途的建议。
Dev Biol Stand. 1993;78:133-7; discussion 138-9.
8
[End phase challenges of poliomyelitis eradication programme realization].[实现脊髓灰质炎根除计划的末期挑战]
Przegl Epidemiol. 2005;59(1):59-68.
9
Risk management in a polio-free world.无脊髓灰质炎世界中的风险管理。
Risk Anal. 2006 Dec;26(6):1441-8. doi: 10.1111/j.1539-6924.2006.00840.x.
10
WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland.世界卫生组织关于1968年波兰脊髓灰质炎流行期间分离出的3型脊髓灰质炎病毒株的合作研究。
Bull World Health Organ. 1972;47(3):287-94.
引用本文的文献
1
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.用于预防脊髓灰质炎的序贯灭活脊髓灰质炎疫苗（IPV）和口服脊髓灰质炎减毒活疫苗（OPV）
Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2.
2
Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden.疫苗相关麻痹型脊髓灰质炎：流行病学综述及全球负担估计
J Infect Dis. 2014 Nov 1;210 Suppl 1(Suppl 1):S380-9. doi: 10.1093/infdis/jiu184.
3
History of polio vaccination.脊髓灰质炎疫苗接种史。
World J Virol. 2012 Aug 12;1(4):108-14. doi: 10.5501/wjv.v1.i4.108.
4
Mass polio vaccination.大规模脊髓灰质炎疫苗接种。
BMJ. 1996 May 11;312(7040):1178-9. doi: 10.1136/bmj.312.7040.1178.
5
Social, economic and psychological impacts of childhood diseases subject to immunization.需接种疫苗的儿童疾病所带来的社会、经济和心理影响。
Infection. 1991 Jul-Aug;19(4):237-41. doi: 10.1007/BF01644952.
6
Poliomyelitis: eradication in sight.脊髓灰质炎：消灭在望。
Epidemiol Infect. 1992 Feb;108(1):1-18. doi: 10.1017/s0950268800049451.
本文引用的文献
1
WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland.世界卫生组织关于1968年波兰脊髓灰质炎流行期间分离出的3型脊髓灰质炎病毒株的合作研究。
Bull World Health Organ. 1972;47(3):287-94.
2
The standardization of infectivity titrations of poliovaccines--a WHO collaborative study.脊髓灰质炎疫苗感染性滴定标准化——一项世界卫生组织合作研究
J Biol Stand. 1985 Apr;13(2):159-66. doi: 10.1016/s0092-1157(85)80022-6.
Zotero 插件